Literature DB >> 30575481

Factor H Autoantibodies and Membranous Nephropathy.

Claudia Seikrit1, Pierre Ronco1, Hanna Debiec1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30575481     DOI： 10.1056/NEJMc1805857

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

2.  Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015-2018.

Authors:  Silvia Perez-Vilar; Graça M Dores; Paige L Marquez; Carmen S Ng; Maria V Cano; Anuja Rastogi; Lucia Lee; John R Su; Jonathan Duffy
Journal:  Vaccine       Date:  2021-12-07       Impact factor: 3.641

Review 3.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

Review 4.  Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.

Authors:  Maryam Saleem; Sana Shaikh; Zheng Hu; Nicola Pozzi; Anuja Java
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

5.  Safety Surveillance of Bivalent Meningococcal Group B Vaccine, Vaccine Adverse Event Reporting System, 2014-2018.

Authors:  Jonathan Duffy; Paige Marquez; Graça M Dores; Carmen Ng; John Su; Maria Cano; Silvia Perez-Vilar
Journal:  Open Forum Infect Dis       Date:  2020-10-27       Impact factor: 3.835

6.  Limited Significance of Antifactor H Antibodies in Patients with Membranous Nephropathy.

Authors:  Amit Sethi; Jing Miao; Maria Alice V Willrich; Jody L Frinack; Daniel C Cattran; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2021-04-15       Impact factor: 10.614

Review 7.  Complement Inhibitors in Clinical Trials for Glomerular Diseases.

Authors:  Peter F Zipfel; Thorsten Wiech; Ramona Rudnick; Sara Afonso; Fermin Person; Christine Skerka
Journal:  Front Immunol       Date:  2019-09-27       Impact factor: 7.561

Review 8.  A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China.

Authors:  Lianzhong Wu; Jin Lai; Yixin Ling; Yiqin Weng; Shujuan Zhou; Siqi Wu; Songfu Jiang; Xiaokai Ding; Xin Jin; Kang Yu; Yi Chen
Journal:  Med Sci Monit       Date:  2021-02-07

9.  Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation.

Authors:  Maël Lateb; Hajar Ouahmi; Christine Payré; Vesna Brglez; Kevin Zorzi; Guillaume Dolla; Mohamad Zaidan; Sonia Boyer-Suavet; Bertrand Knebelmann; Thomas Crépin; Cécile Courivaud; Noémie Jourde-Chiche; Vincent Esnault; Gérard Lambeau; Barbara Seitz-Polski
Journal:  J Immunol Res       Date:  2019-12-30       Impact factor: 4.818

Review 10.  Mechanisms of Primary Membranous Nephropathy.

Authors:  Yan Gu; Hui Xu; Damu Tang
Journal:  Biomolecules       Date:  2021-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.